Skip to main content
. 2019 Sep 18;15(3):328–337. doi: 10.5114/aic.2019.87887

Table I.

Patient baseline characteristics and indications for treatment

Parameter DES (n = 144) BMS (n = 270) P-value
Demography:
 Age [years] 66.6 ±8.5 67.5 ±8.6 0.080
 Men, n (%) 98 (68.1) 195 (72.2) 0.375
Comorbidities, n (%):
 Coronary artery disease 89 (61.8) 149 (55.2) 0.194
 Previous myocardial infarction 41 (28.5) 72 (26.7) 0.694
 Previous percutaneous coronary intervention 43 (29.9) 69 (25.6) 0.348
 History of coronary artery bypass grafting 15 (10.4) 36 (13.3) 0.389
 Previous carotid artery stenting 34 (23.6) 56 (20.7) 0.500
 Carotid artery occlusion 32 (22.2) 73 (27) 0.284
 Previous percutaneous transluminal angioplasty in peripheral vascular disease 6 (4.2) 17 (6.3) 0.367
 Previous carotid endarterectomy 8 (5.6) 7 (2.6) 0.124
 Hypertension 138 (95.8) 268 (99.3) 0.016
 Dyslipidaemia 133 (92.4) 264 (97.8) 0.008
 Diabetes mellitus 45 (31.3) 69(25.6) 0.217
 Insulin therapy 15 (10.4) 26 (9.6) 0.798
 Symptomatic peripheral artery disease 32 (22.2) 53 (19.6) 0.533
Indications for treatment, n (%):
 Vertigo, dizziness 136 (94.4) 252 (93.3) 0.657
 VBS stroke 65 (45.1) 114 (42.2) 0.568
 VBS TIA 35 (24.3) 65 (24.1) 0.958
 Occipital lobe stroke 15 (10.4) 26 (9.6) 0.798
 Recurrent syncope 25 (17.4) 55 (20.4) 0.460
 Tinnitus 1 (0.7) 4 (1.5) 0.485

Continuous data are presented as the mean ± standard deviation; categorical data are given as the count (percentage).